Modification to change closing date to January 22, 2025.

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2245421 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-01 Nov. 12, 2024.

The North American Industry Classification System (NAICS) code for this procurement is 811210, ELECTRONIC AND PRECISION EQUIPMENT REPAIR AND MAINTENANCE,

with a size standard of 34M employees. The requirement will be competed full and open without restrictions which will include the minimum specifications.

The VRC Virology Laboratory comprises the Virology Core Lab, Humoral Immunology, and Structural Biology Sections and related Cores. The goal of the Virology Laboratory is to research and understand better the cellular and molecular regulation of viral gene expression, viral entry into the host cell, optimization of immune responses to gene-based vaccination and correlates of immune protection, assessment of active and passive approaches for viral vaccine development, and to apply structural biology techniques toward rational vaccine design for emerging and re-emerging infectious diseases. The work of the Virology Core Laboratory is closely integrated with other VRC basic and translational research Laboratories and Cores.  Therefore, the data collected using the said equipment will facilitate and impact VRC research and develop novel vaccine candidates against pathogens threatening public health.

The goal of the VRC is to translate basic research into concrete vaccine products that can be rapidly deployed to protect public health.  The Preventive Service maintenance agreement includes a Gold Service Plan for one onsite PM for both the Microbeta2 Lumijet with 6 detectors and Microbeta2 Lumijet with 12 detectors.  To have reliable and reproducible data collected from this equipment, the equipment must be under preventive maintenance and repair to maintain consistent performance and minimize downtimes.  discuss any project background that is important to understand this acquisition.

The requested renewal is for a 12-month Gold Service Plan for both Microbeta2 Lumijets, with the benefit of one onsite PM for the Microbeta 2 Lumijet with 6 detectors and the Microbeta2 Lumijet with 12 detectors.

       MICROBETA2 LUMIJET WITH 6 DETECTORS. Serial  (SGMB30140101) QTY-1

• Gold Service Plan with 1PM
• 1 Preventive Maintenance visit
• Unlimited Repair Service - Non-consumable Parts, Labor, Travel
• Phone/Remote Support
• 15% Discount on Training / 10% Discount on Qualification Services

MICROBETA2 LUMIJET WITH 12 DETECTORS. Serial (SGMB23170382) QTY-1

• Gold Service Plan with 1PM
• 1 Preventive Maintenance visit
• Unlimited Repair Service - Non-consumable Parts, Labor, Travel
• Phone/Remote Support, 15% Discount on Training / 10% Discount on Qualification Services

Place of Performance: NIH, NIAID, 40 CONVENT DRIVE, BLDG 40, RM 4606, BETHESDA, MD 20892

Period of Performance will begin after receipt and acceptance of award.

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: technical capability to meet the requirements, price, and delivery.

By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual represen